NURS-6521N-14 Advanced Pharmacology Exam_2022 || 94 out of 100 Points
A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast cancer. Her medical record indicates she has cardiomyopathy and a cumulative dose of 300 mg/m2 of doxorubicin. Which of the following measures would help limit the severity of the cardiomyopathy in this patient? Selected Answer: The use of dexrazoxane in conjunction with doxorubicin NURS-6521N-14 Advanced Pharmacology Exam_2022 Winter Qtr 11 25-02/16-PT27 Exam – Week 11 94 out of 100 Points Review Test Submission Exam – Week 11 A patient with non-Hodgkin's lymphoma (NHL) will be starting a course of doxorubicin shortly. When planning this patient's care, what nursing diagnosis should the nurse prioritize? Selected Answer: Risk for Infection related to suppressed bone marrow function
Written for
- Institution
- NURS-6521N-14
- Course
- NURS-6521N-14
Document information
- Uploaded on
- November 15, 2022
- Number of pages
- 46
- Written in
- 2022/2023
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
- nurs 6521n 14
- advanced pharmacology
- advanced pha
-
nurs 6521n 14 advanced pharmacology exam2022 || 94 out of 100 points
-
nurs 6521n 14 advanced pharmacology exam2022
-
nurs 6521n 14 advanced pharmacology
